DK1558929T3 - Kvantificering af stresseksponering - Google Patents

Kvantificering af stresseksponering

Info

Publication number
DK1558929T3
DK1558929T3 DK03810513T DK03810513T DK1558929T3 DK 1558929 T3 DK1558929 T3 DK 1558929T3 DK 03810513 T DK03810513 T DK 03810513T DK 03810513 T DK03810513 T DK 03810513T DK 1558929 T3 DK1558929 T3 DK 1558929T3
Authority
DK
Denmark
Prior art keywords
quantification
neutrophils
stress exposure
exposure
stress
Prior art date
Application number
DK03810513T
Other languages
English (en)
Inventor
David Whyte Macdonald
Rubina Mian
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of DK1558929T3 publication Critical patent/DK1558929T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Ecology (AREA)
  • Physiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Holo Graphy (AREA)
DK03810513T 2002-11-06 2003-11-05 Kvantificering af stresseksponering DK1558929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0225885.3A GB0225885D0 (en) 2002-11-06 2002-11-06 Quantifying exposure to stress
PCT/GB2003/004749 WO2004042395A1 (en) 2002-11-06 2003-11-05 Quantifying exposure to stress

Publications (1)

Publication Number Publication Date
DK1558929T3 true DK1558929T3 (da) 2009-01-26

Family

ID=9947318

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03810513T DK1558929T3 (da) 2002-11-06 2003-11-05 Kvantificering af stresseksponering

Country Status (10)

Country Link
US (1) US7838262B2 (da)
EP (1) EP1558929B1 (da)
JP (1) JP4571864B2 (da)
AT (1) ATE408827T1 (da)
AU (1) AU2003276448A1 (da)
DE (1) DE60323661D1 (da)
DK (1) DK1558929T3 (da)
ES (1) ES2312854T3 (da)
GB (1) GB0225885D0 (da)
WO (1) WO2004042395A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201616640D0 (en) * 2016-09-30 2016-11-16 Sarphie David And Mian Rubina Monitoring cancer recurrence and progression
US20220308046A1 (en) 2019-06-27 2022-09-29 Binary Llc Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)
WO2022136850A1 (en) 2020-12-22 2022-06-30 Seroxo Limited Method for diagnosing and monitoring sepsis
GB2619197A (en) 2021-02-02 2023-11-29 Seroxo Ltd Monitoring COVID-19 progression and treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401640A (en) * 1992-03-30 1995-03-28 Trustees Of Dartmouth College Method for enhancing detection of superoxide anion
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
EP1262167A1 (de) * 2001-06-01 2002-12-04 Cognis France S.A. Kosmetische Zubereitungen enthaltend ein Extrakt von keimenden Pflanzen
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
AU2005229008B2 (en) * 2004-03-23 2011-03-24 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal

Also Published As

Publication number Publication date
DE60323661D1 (de) 2008-10-30
US20060014235A1 (en) 2006-01-19
AU2003276448A1 (en) 2004-06-07
ES2312854T3 (es) 2009-03-01
EP1558929A1 (en) 2005-08-03
US7838262B2 (en) 2010-11-23
JP4571864B2 (ja) 2010-10-27
GB0225885D0 (en) 2002-12-11
JP2006505263A (ja) 2006-02-16
EP1558929B1 (en) 2008-09-17
ATE408827T1 (de) 2008-10-15
WO2004042395A1 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
FI20041323A0 (fi) Analysoija, järjestelmä ja menetelmä toivotun käyttäjäjoukon määrittämiseksi
EP1691192A4 (en) METHOD FOR MEASURING A BLOOD COMPOUND, DETECTOR USED FOR THE SAME, AND MEASURING INSTRUMENT
DE60228557D1 (de) Candida-nachweis
EP1677097A4 (en) METHOD AND SYSTEM FOR DETERMINING THE CONCENTRATION OF A FLUORESCENT PIGMENT
AU2003228700A1 (en) Non-invasive substance concentration measurement using an optical bridge
EP1939583A4 (en) OPTICAL DEVICE, AND METHOD FOR MEASURING THE DIMENSION OF AN OBJECT USING THE OPTICAL DEVICE
DK2211183T3 (da) Fremgangsmåde til diagnosticering og overvågning af Alzheimer's sygdom
NO339666B1 (no) Fremgangsmåte og system for rapportering av utviklete UTRAN-egenskaper
EP1630562A4 (en) DYNAMIC MATRIX SENSITIVITY MEASURING INSTRUMENT FOR INTERNAL SENSORS AND ASSOCIATED METHOD OF MEASUREMENT
FI20030867A (fi) Optinen mittausmenetelmä ja laboratoriomittauslaite
EP1921439A4 (en) DEVICE, INSTRUMENT AND METHOD OF MEASUREMENT
DK1510492T3 (da) Fremgangsmåde til afprövning af et elevatoranlæg og elevatoranlæg
HK1089231A1 (en) Light wavefront measuring instrument, light wavefront measuring method, and light source adjusting method
NO20081343L (no) Biosensor-måleanordning, biosensor-målesystem og biosensor-målemetode
DK1630527T3 (da) Optisk forskydningstransducer, forskydningsmålesystem og fremgangsmåde
WO2004081521A3 (en) Methods for direct detection of individual methotrexate metabolites
DK1558929T3 (da) Kvantificering af stresseksponering
WO2004113574A3 (en) Methods for disease screening
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
DE60329360D1 (de) Wheatstonebrücke
WO2007075318A3 (en) Agents that reduce apoe-induced impairment of mitochondria and methods of use thereof
TW200508936A (en) The establishment of proteome structure profile databases and their uses
FI20011362A (fi) Röntgenfluoresenssianalysaattori ja menetelmä röntgenfluoresenssianalysaattorin käyttämiseksi
DK1257830T3 (da) Assay til måling af holo-transcobalamin og folat
ITRM20040433A1 (it) Dispositivo ottico per la misura in linea di radiazioni elettromagnetiche.